ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | -100.0% | 290 | -29.3% | 0.00% | – |
| Q4 2019 | $1,000 | -85.7% | 410 | -83.7% | 0.00% | – |
| Q3 2019 | $7,000 | +40.0% | 2,514 | +251.1% | 0.00% | – |
| Q2 2019 | $5,000 | -68.8% | 716 | -41.0% | 0.00% | – |
| Q1 2019 | $16,000 | -11.1% | 1,214 | +3.2% | 0.00% | – |
| Q4 2018 | $18,000 | -48.6% | 1,176 | -34.8% | 0.00% | – |
| Q3 2018 | $35,000 | -31.4% | 1,803 | +1.6% | 0.00% | – |
| Q2 2018 | $51,000 | +34.2% | 1,774 | +11.4% | 0.00% | – |
| Q1 2018 | $38,000 | +81.0% | 1,593 | +62.1% | 0.00% | – |
| Q4 2017 | $21,000 | -40.0% | 983 | -32.6% | 0.00% | – |
| Q3 2017 | $35,000 | +66.7% | 1,458 | +38.2% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 1,055 | +2.6% | 0.00% | – |
| Q1 2017 | $21,000 | +31.2% | 1,028 | +19.3% | 0.00% | – |
| Q4 2016 | $16,000 | -83.3% | 862 | -81.1% | 0.00% | – |
| Q3 2016 | $96,000 | -51.0% | 4,553 | -41.0% | 0.00% | – |
| Q2 2016 | $196,000 | +429.7% | 7,712 | +440.4% | 0.00% | – |
| Q1 2016 | $37,000 | -22.9% | 1,427 | +26.4% | 0.00% | – |
| Q4 2015 | $48,000 | +108.7% | 1,129 | +26.3% | 0.00% | – |
| Q3 2015 | $23,000 | -36.1% | 894 | -17.5% | 0.00% | – |
| Q2 2015 | $36,000 | +28.6% | 1,084 | +30.4% | 0.00% | – |
| Q1 2015 | $28,000 | -73.1% | 831 | -67.4% | 0.00% | – |
| Q4 2014 | $104,000 | +2500.0% | 2,547 | +1859.2% | 0.00% | – |
| Q3 2014 | $4,000 | 0.0% | 130 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | -82.6% | 130 | -78.9% | 0.00% | – |
| Q1 2014 | $23,000 | +21.1% | 616 | -5.1% | 0.00% | – |
| Q4 2013 | $19,000 | -20.8% | 649 | -6.5% | 0.00% | – |
| Q3 2013 | $24,000 | +4.3% | 694 | +1.5% | 0.00% | – |
| Q2 2013 | $23,000 | – | 684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |